Archived explainer. For the current picture see today's BHC page.
Why Is BAUSCH HEALTH COS IN (BHC) Stock Up Today?
By the Top Tier Newswire AI Desk · July 30, 2026 at 10:24 AM ET · reviewed against 5 wire stories
BAUSCH HEALTH COS IN (BHC) is up +25.35% in the latest session. Our newswire has captured 5 stories on BHC across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 61/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Bausch Health Companies Inc. (BHC) surged 25.35% to $5.87 in early trading on Tuesday following the release of its second-quarter 2026 earnings report. The stock opened with a 3.6% gap up and climbed further after the company reported better-than-expected results and raised its full-year guidance. The move reflects strong performance in both revenue and adjusted earnings, as well as positive sentiment toward the firm’s updated outlook.
What Happened
Bausch Health reported second-quarter non-GAAP earnings per share of $1.26, exceeding the $1.04 estimate. Consolidated revenues reached $2.85 billion, up 13% year-over-year on a reported basis and 11% on an organic (non-GAAP) basis. The company also raised its full-year 2026 guidance, with a new revenue range of $10.790 billion to $11.040 billion, surpassing the $10.773 billion consensus estimate. These results were disclosed in a Form 8-K filing and highlighted in multiple reports, including the earnings call transcript and press releases from the company.
The stock’s sharp rise was fueled by the combination of revenue growth, earnings beat, and the upward revision to guidance. The company also announced new provincial drug listings in Canada, including PrELIDEL Cream in Alberta and Prokedi in Quebec, which may signal long-term expansion in its therapeutic offerings.
What The Data Shows
Bausch Health’s stock opened at $4.85 and climbed to an intraday high of $5.97 before settling near $5.88. The session saw a volume of 5.3 million shares, more than double the 3-month daily average. Despite the recent rally, the stock remains within its 52-week range of $4.33 to $8.69. The company has a market cap of $1.7 billion and a trailing 12-month revenue growth of 8.2%. However, it remains unprofitable with a net margin of -11.5% and a TTM EPS of -3.25.
What To Watch
The company’s next key event will be its Q2 2026 earnings call on July 29, 2026, where further details on performance and strategy will be discussed. Investors should also monitor coverage breadth and any follow-up analyst commentary in the coming days.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
BHC · Jul 30 session (5-min) · +26.50% vs prior close · updated 8:55 PM ETAI sentiment, last 36h · averaged over 5 stories · 61/100 bullish
The headlines behind the move
Story flow · 5 stories on the wire, last 36h · hover or tap a dot for the headline
11d agoSeeking AlphaNEUTRAL 50Earnings
Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call Transcript
Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call July 29, 2026 5:00 PM EDTCompany ParticipantsGaren Sarafian - VP & Head of Investor...
12d agoSeeking AlphaBULLISH 68Earnings
Bausch Health Companies Non-GAAP EPS of $1.26 beats by $0.25, revenue of $2.85B beats by $190M
Bausch Health (BHC) Q2 earnings beat: EPS $1.26, revenue +12.6% to $2.85B, and raised 2026 guidance incl. tariffs.
12d agoSEC 8-KNEUTRAL 50General
Bausch Health Companies Inc. (BHC) files 8-K
Filed: 2026-07-29 AccNo: 0000885590-26-000105 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
12d agoPR NewswireBULLISH 68Earnings
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
Second Quarter Consolidated Revenues of $2.85 billion, up 13% on a Reported basis and 11% on an Organic (non-GAAP)1 basis over the prior year period GAAP Net Income Attributable to Bausch Health of $258 million and GAAP Net Income of $260 million GAAP Earnings per Diluted Share...
12d agoStockTitanBULLISH 68Earnings
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE | BHC Stock News
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →